| 2 | 1/1 | 返回列表 |
| 查看: 682 | 回復: 1 | |||
[交流]
怎么翻譯啊求助,JBT-101是什么求告知
|
|
abstract Ajulemic acid, a side-chain analog of D8 -THC-11-oic acid, was designed as a potent therapeutic agent free of the psychotropic adverse effects typical of most cannabinoids. Subsequent studies of ajulemic acid have yielded widely divergent findings on the occurrence of these adverse effects. To help resolve these discrepancies, we have prepared highly purified ajulemic acid using a different synthetic method than previously reported in the literature and compared its cannabinoid receptor binding constants with those obtained using several other preparations from different sources. Whereas CB2 binding did not vary greatly among all of the samples, the CB1 binding showed a wide range of affinities. The highly purified product (JBT-101) reported here had the weakest affinity for CB1 while the original preparation (HU-239) showed the strongest affinity for CB1. The CB1/CB2 ratio of affinities was 12.3 for JBT-101 whereas that for HU-239 was 0.19, a 65-fold difference. Functional responses such as catalepsy and hypothermia using JBT-101 versus HU-239 displayed reduced CB1 activity in keeping with the receptor binding data. Thus, earlier conclusions on the limited therapeutic index for ajulemic acid need to be reconsidered in the light of the data now obtained using JBT-101. 發(fā)自小木蟲Android客戶端 |
|
abstract Ajulemic acid, a side-chain analog of D8 -THC-11-oic acid, was designed as a potent therapeutic agent free of the psychotropic adverse effects typical of most cannabinoids. Subsequent studies of ajulemic acid have yielded widely divergent findings on the occurrence of these adverse effects. To help resolve these discrepancies, we have prepared highly purified ajulemic acid using a different synthetic method than previously reported in the literature and compared its cannabinoid receptor binding constants with those obtained using several other preparations from different sources. Whereas CB2 binding did not vary greatly among all of the samples, the CB1 binding showed a wide range of affinities. The highly purified product (JBT-101) reported here had the weakest affinity for CB1 while the original preparation (HU-239) showed the strongest affinity for CB1. The CB1/CB2 ratio of affinities was 12.3 for JBT-101 whereas that for HU-239 was 0.19, a 65-fold difference. Functional responses such as catalepsy and hypothermia using JBT-101 versus HU-239 displayed reduced CB1 activity in keeping with the receptor binding data. Thus, earlier conclusions on the limited therapeutic index for ajulemic acid need to be reconsidered in the light of the data now obtained using JBT-101. 發(fā)自小木蟲Android客戶端 |
| 2 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 279求調(diào)劑 +12 | j的立方 2026-03-29 | 12/600 |
|
|---|---|---|---|---|
|
[考研] 生物學學碩,一志愿湖南大學,初試成績338 +7 | YYYYYNNNNN 2026-03-26 | 9/450 |
|
|
[考研] 309求調(diào)劑 +15 | 誰不是少年 2026-03-29 | 15/750 |
|
|
[考研] 311求調(diào)劑 +7 | 藍月亮亮 2026-03-30 | 7/350 |
|
|
[考研] 抱歉 +3 | 田洪有 2026-03-30 | 3/150 |
|
|
[考研] 考研調(diào)劑 +5 | Sanmu-124 2026-03-26 | 5/250 |
|
|
[考研] 070300化學354求調(diào)劑 +7 | 101次希望 2026-03-28 | 7/350 |
|
|
[考研] 085602 化學工程專碩 340分求調(diào)劑 +4 | qianbai11 2026-03-29 | 4/200 |
|
|
[考研] 295求調(diào)劑 +5 | wei-5 2026-03-26 | 5/250 |
|
|
[考研] 求調(diào)劑 +4 | QiMing7 2026-03-25 | 5/250 |
|
|
[考研] 081200-11408-276學碩求調(diào)劑 +6 | 崔wj 2026-03-26 | 6/300 |
|
|
[考研] 一志愿太原理工安全工程300分,求調(diào)劑 +5 | 0857求調(diào)劑. 2026-03-24 | 6/300 |
|
|
[考研] 315求調(diào)劑 +4 | akie... 2026-03-28 | 5/250 |
|
|
[考研] 347求調(diào)劑 +3 | 山頂見α 2026-03-25 | 3/150 |
|
|
[考研] 085405 考的11408求各位老師帶走 +3 | Qiu學ing 2026-03-28 | 3/150 |
|
|
[考研] 330一志愿中國海洋大學 化學工程 085602 有讀博意愿 求調(diào)劑 +3 | wywy.. 2026-03-27 | 4/200 |
|
|
[考研] 一志愿 南京郵電大學 288分 材料考研 求調(diào)劑 +3 | jl0720 2026-03-26 | 3/150 |
|
|
[考研] 打過很多競賽,085406控制工程300分,求調(diào)劑 +3 | askeladz 2026-03-26 | 3/150 |
|
|
[考研] 材料與化工304求B區(qū)調(diào)劑 +3 | 邱gl 2026-03-25 | 3/150 |
|
|
[考研] 302求調(diào)劑 +4 | 錦衣衛(wèi)藤椒 2026-03-25 | 4/200 |
|